Unknown

Dataset Information

0

Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study.


ABSTRACT: Objective:The rationale of this study was to evaluate the efficacy of dog-assisted therapy (DAT) combined with pharmacological treatment in children and adolescents with fetal alcohol spectrum disorder (FASD). Method:We conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n = 17) or Treatment as Usual (TAU control group) (n = 16). Results:Of the initial 39 participants enrolled, 33 completed treatment. A mixed-effects model analysis revealed that participants who were assigned to the DAT group experienced significantly improvements on social skills (SSIS-P social skills: p = 0.02, d = 0.8), reductions on externalizing symptoms (CBCL externalizing: p = 0.03; d = 0.56), and lower scores on FASD severity (CGI-S clinician: p = 0.001, d = 0.5). Conclusion:DAT is a promising adjunctive treatment for children and adolescents with FASD. Clinical Trial Registration:Dog-assisted therapy for children and adolescents with fetal alcohol spectrum disorders: a randomized controlled pilot study; http://clinicaltrials.gov/, identifier NCT04038164.

SUBMITTER: Vidal R 

PROVIDER: S-EPMC7264372 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study.

Vidal Raquel R   Vidal Laura L   Ristol Francesc F   Domènec Eva E   Segú Marta M   Vico Cristina C   Gomez-Barros Núria N   Ramos-Quiroga Josep Antoni JA  

Frontiers in psychology 20200526


<h4>Objective</h4>The rationale of this study was to evaluate the efficacy of dog-assisted therapy (DAT) combined with pharmacological treatment in children and adolescents with fetal alcohol spectrum disorder (FASD).<h4>Method</h4>We conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group (<i>n</i> = 17) or Treatment as Usual (TAU control group) (<i>n</i> = 16).<h4>Results</h4>Of  ...[more]

Similar Datasets

| S-EPMC8532616 | biostudies-literature
| S-EPMC4625582 | biostudies-literature
| S-EPMC5855388 | biostudies-literature
| S-EPMC3632441 | biostudies-literature
| S-EPMC5125635 | biostudies-literature
| S-EPMC4207054 | biostudies-literature
| S-EPMC5609722 | biostudies-literature
| S-EPMC8504395 | biostudies-literature
| S-EPMC5118735 | biostudies-literature
| S-EPMC3815698 | biostudies-literature